NEUARTIGE HETERODIMERE PROTEINE

European patent · EP3620473 · In force

Register entry

Publication number
EP3620473
Application number
EP19187150
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 14, 2014
Published
Mar 11, 2020
Granted
May 27, 2026
Protection ends at the latest
Jan 13, 2034
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/46 (2006.01)
Priority
US 201361752348 P 14.01.2013
US 201361764954 P 14.02.2013
US 201361778157 P 12.03.2013
US 201361780334 P 13.03.2013
US 201361818153 P 01.05.2013
US 201361818410 P 01.05.2013
US 201361913832 P 09.12.2013
US 201361913870 P 09.12.2013
Divided from
EP14738267
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 26, 2026

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 26.06.2026

  2. May 27, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.05.2026

Parties

Holder

Xencor, Inc.

465 North Halstead Street Suite 200, Pasadena, CA 91107, US

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

DESJARLAIS, John

Monrovia, CA 91016, US

MOORE, Gregory

Monrovia, CA 91016, US

RASHID, Rumana

Monrovia, CA 91016, US

BERNETT, Matthew J.

Monrovia, CA 91016, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.